LABOCANNA S.A. ZY-10 (9Y2) - Net Assets
Based on the latest financial reports, LABOCANNA S.A. ZY-10 (9Y2) has net assets worth €6.05 Million EUR (≈ $7.07 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€13.75 Million ≈ $16.08 Million USD) and total liabilities (€7.71 Million ≈ $9.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 9Y2 financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €6.05 Million |
| % of Total Assets | 43.96% |
| Annual Growth Rate | -7.37% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1.31 |
LABOCANNA S.A. ZY-10 - Net Assets Trend (2022–2025)
This chart illustrates how LABOCANNA S.A. ZY-10's net assets have evolved over time, based on quarterly financial data. Also explore 9Y2 total asset value for the complete picture of this company's asset base.
Annual Net Assets for LABOCANNA S.A. ZY-10 (2022–2025)
The table below shows the annual net assets of LABOCANNA S.A. ZY-10 from 2022 to 2025. For live valuation and market cap data, see market value of LABOCANNA S.A. ZY-10.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €6.05 Million ≈ $7.07 Million |
-5.57% |
| 2024-12-31 | €6.40 Million ≈ $7.48 Million |
-8.66% |
| 2023-12-31 | €7.01 Million ≈ $8.19 Million |
-7.87% |
| 2022-12-31 | €7.61 Million ≈ $8.89 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to LABOCANNA S.A. ZY-10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 175211135.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €11.42 Million | 189.57% |
| Total Equity | €6.02 Million | 100.00% |
LABOCANNA S.A. ZY-10 Competitors by Market Cap
The table below lists competitors of LABOCANNA S.A. ZY-10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SDI Group plc
LSE:SDI
|
$954.26K |
|
Gemfields Plc
LSE:GEM
|
$954.54K |
|
Tangiamo Touch Technology AB
ST:TANGI
|
$956.09K |
|
Argo Blockchain PLC ADR
NASDAQ:ARBK
|
$957.54K |
|
4BASEBIO UK SOCIETAS
LSE:4BB
|
$951.45K |
|
Quhuo Ltd
NASDAQ:QH
|
$950.17K |
|
Fort St James Nickel Corp
V:FTJ
|
$949.38K |
|
Transforma Resources Corp
V:TFM
|
$947.04K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LABOCANNA S.A. ZY-10's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,402,027 to 6,021,749, a change of -380,279 (-5.9%).
- Net loss of 597,866 reduced equity.
- Other factors increased equity by 217,588.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-597.87K | -9.93% |
| Other Changes | €217.59K | +3.61% |
| Total Change | €- | -5.94% |
Book Value vs Market Value Analysis
This analysis compares LABOCANNA S.A. ZY-10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.14x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | €0.36 | €0.04 | x |
| 2023-12-31 | €0.33 | €0.04 | x |
| 2024-12-31 | €0.30 | €0.04 | x |
| 2025-12-31 | €0.28 | €0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LABOCANNA S.A. ZY-10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4554.80%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 2.28x
- Recent ROE (-9.93%) is above the historical average (-10.88%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -15.58% | -40428.72% | 0.00x | 1.16x | €-1.95 Million |
| 2023 | -8.54% | -3624.46% | 0.00x | 1.08x | €-1.30 Million |
| 2024 | -9.48% | -24275.49% | 0.00x | 1.26x | €-1.25 Million |
| 2025 | -9.93% | -4554.80% | 0.00x | 2.28x | €-1.20 Million |
Industry Comparison
This section compares LABOCANNA S.A. ZY-10's net assets metrics with peer companies in the Specialty Business Services industry.
Industry Context
- Industry: Specialty Business Services
- Average net assets among peers: $-48,801,726
- Average return on equity (ROE) among peers: -6.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LABOCANNA S.A. ZY-10 (9Y2) | €6.05 Million | -15.58% | 1.27x | $951.62K |
| Cimpress plc (3UF) | $-363.44 Million | 0.00% | 0.00x | $1.70 Billion |
| CPPGroup Plc (4CV1) | $14.47 Million | 3.61% | 3.12x | $4.97 Million |
| SG COMPANY S.P.A. (7KZ) | $3.13 Million | 6.08% | 3.24x | $7.34 Million |
| Bastogi S.p.A (BAOA) | $14.03 Million | -42.93% | 3.18x | $140.24 Million |
| Francotyp-Postalia Holding AG (FPH) | $33.31 Million | 2.69% | 4.01x | $47.81 Million |
| NorCom Information Technology GmbH & Co. KGaA (NC5A) | $5.69 Million | -6.74% | 1.12x | $2.79 Million |
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its name to Labocanna S.A. in January 2021. Labocanna S.A. was incorporat… Read more